Filing Flows › Comparisons › BVS vs AORT
Bioventus vs Artivion: BVS and AORT compared
Bioventus is the larger company: $142M of revenue in its latest quarter (Q3 2026) against $124M for Artivion (Q3 2026). Artivion is growing faster (+9% against +3% a year earlier). Bioventus is more profitable, with an operating margin of 6.8% against 2.4%.
Where the money goes: BVS and AORT
Bioventus (BVS) · Q3 2026
Bioventus, Q3 2026: revenue $142M (+3% year over year), operating margin 6.8%, net earnings $6.0M, operating cash flow $20.7M. The chart follows the revenue to costs, profit and cash.
Artivion (AORT) · Q3 2026
Artivion, Q3 2026: revenue $124M (+9% year over year), operating margin 2.4%, net loss $7.9M, operating cash flow −$4.6M. The chart follows the revenue to costs, profit and cash.
| Bioventus (BVS) | Artivion (AORT) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $142M | $124M |
| Revenue growth, Y/Y | +3% | +9% |
| Gross margin | 68.2% | — |
| Operating margin | 6.8% | 2.4% |
| Net earnings | $6.0M | −$7.9M |
| Net margin | 4.2% | -6.4% |
| Operating cash flow | $20.7M | −$4.6M |
| Free cash flow | $20.3M | — |
Where the revenue comes from
Artivion
- Products: $98.2M (79%)
- Preservation services: $25.6M (21%)
Questions
Which is bigger, Bioventus or Artivion?
Bioventus is the larger company: $142M of revenue in its latest quarter (Q3 2026) against $124M for Artivion (Q3 2026).
Is Bioventus or Artivion growing faster?
Artivion is growing faster (+9% against +3% a year earlier).
Which is more profitable, Bioventus or Artivion?
Bioventus is more profitable, with an operating margin of 6.8% against 2.4%.
More: Bioventus earnings · how Bioventus makes money · Artivion earnings · how Artivion makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 2, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.